Intriguingly, mutants of human IFITM3 that lack the capacity to internalize into endosomes lost antiviral activity and promoted SARS-CoV-2 and MERS-CoV infection, revealing that IFITM3 can either inhibit or enhance infection depending on its subcellular localization (47, 80). The gene discussed is IFITM3; the disease is infection.